Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alexander Pedroza-Gonzalez, Julia Reyes-Reali, Maricela Campos-Solorzano, Eloy Moises Blancas-Diaz, Janik Adriana Tomas-Morales, Aldo Aram Hernandez-Aparicio, Daniel Montes de Oca-Samperio, Efrain Garrido, Gina Stella Garcia-Romo, Claudia Fabiola Mendez-Catala, Patricia Alvarez Ortiz, Janet Sánchez Ramos, Maria Isabel Mendoza-Ramos, Alberto Daniel Saucedo-Campos & Glustein Pozo-Molina. (2022) Human papillomavirus infection and seroprevalence among female university students in Mexico. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Jing Yang, Wei Wang, Zhe Wang, Zhilian Wang, Yonghong Wang, Jintao Wang, Weihong Zhao, Dongyan Li, Huiqiang Liu & Min Hao. (2020) Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women. Human Vaccines & Immunotherapeutics 16:7, pages 1645-1652.
Read now
Read now
Jacqueline Hirth. (2019) Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Human Vaccines & Immunotherapeutics 15:1, pages 146-155.
Read now
Read now
Articles from other publishers (22)
Wenjie Qu, Long Sui & Yanyun Li. (2023) Vaccine escape challenges virus prevention: The example of two vaccine‐preventable oncogenic viruses. Journal of Medical Virology 95:11.
Crossref
Crossref
Anna Loenenbach, Viktoria Schönfeld, Anja Takla, Miriam Wiese-Posselt, Adine Marquis, Sarah Thies, Matthias Sand, Andreas M. Kaufmann, Ole Wichmann & Thomas Harder. (2023) Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study. Frontiers in Public Health 11.
Crossref
Crossref
Christelle Auvray, Serge Douvier, Odile Caritey, Jean-Baptiste Bour & Catherine Manoha. (2023) Relative distribution of HPV genotypes in histological cervical samples and associated grade lesion in a women population over the last 16 years in Burgundy, France. Frontiers in Medicine 10.
Crossref
Crossref
Yingxin Gong, Yan Wang, Qi Zhou, Wenjie Qu, Fang Chen, Yaping Wang, Jiayin Mo, Hongwei Zhang, Lin Lin, Tianyi Bi, Xujie Wang, Jiashi Gu, Long Sui & Yanyun Li. (2023) The possible impact of novel mutations in human papillomavirus 52 on the infection characteristics. Microbial Genomics 9:4.
Crossref
Crossref
Chenxi Li, Thomas G. Hall, John J. Hall & Wen-Qiang He. (2023) Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection. Epidemiology and Infection 151.
Crossref
Crossref
Yingxin Gong, Long Sui & Yanyun Li. (2022) Recombination in Papillomavirus: Controversy and Possibility. Virus Research 314, pages 198756.
Crossref
Crossref
Alba L. Combita, Viviana Reyes, Devi Puerto, Raúl Murillo, Ricardo Sánchez, Marcela Nuñez, Gustavo A. Hernandez-Suarez & Carolina Wiesner. (2022) Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia. Cancer Prevention Research 15:1, pages 55-66.
Crossref
Crossref
Liliana Veronica Diaconescu, Iuliana Raluca Gheorghe, Tamara Cheşcheş & Ovidiu Popa-Velea. (2021) Psychological Variables Associated with HPV Vaccination Intent in Romanian Academic Settings. International Journal of Environmental Research and Public Health 18:17, pages 8938.
Crossref
Crossref
Gabriel Chodick, Amy E. Leader & Sharon Larson. (2021) Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System. Cancer Prevention Research 14:4, pages 415-420.
Crossref
Crossref
Kalysha Closson, Mohammad E. Karim, Manish Sadarangani, Monika Naus, Gina S. Ogilvie & Robine Donken. (2020) Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis. Vaccine 38:52, pages 8396-8404.
Crossref
Crossref
Mahin Khatami. (2020) Retracted: Deceptology in cancer and vaccine sciences: Seeds of immune destruction‐mini electric shocks in mitochondria: Neuroplasticity‐electrobiology of response profiles and increased induced diseases in four generations – A hypothesis. Clinical and Translational Medicine 10:8.
Crossref
Crossref
Espen Enerly, Ragnhild Flingtorp, Irene Kraus Christiansen, Suzanne Campbell, Mona Hansen, Tor Åge Myklebust, Elisabete Weiderpass & Mari Nygård. (2019) An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway. PLOS ONE 14:10, pages e0223612.
Crossref
Crossref
Steven Van Schandevyl, Liselotte Coorevits, Jerina Boelens, Ans Traen, Luc Bingé, Marleen Praet, Jo Van Dorpe & Elizaveta Padalko. (2018) Detection of human papillomavirus 67 single infection in high‐grade cervical lesions: Case report and review of literature. Diagnostic Cytopathology 47:3, pages 251-254.
Crossref
Crossref
Naomi R Lee, Rachel L Winer, Stephen Cherne, Carolyn J Noonan, Lonnie Nelson, Angela A Gonzales, Jason G Umans & Dedra Buchwald. (2019) Human Papillomavirus Prevalence Among American Indian Women of the Great Plains. The Journal of Infectious Diseases 219:6, pages 908-915.
Crossref
Crossref
Akihiro Karube, Fumiko Saito, Enami Nakamura, Akihiro Shitara, Natsuki Ono, Megumi Konno, Daisuke Tamura & Daisuke Nagao. (2019) Reduction in HPV 16/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008–2017. Journal of Rural Medicine 14:1, pages 48-57.
Crossref
Crossref
E. V. Belyaeva, O. A. TokarskayaT. S. BelokhvostikovaТ. A. Bairova. (2018) FREQUENCY OF HUMAN PAPILLOMA VIRUS IN IRKUTSK POPULATION. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 3:5, pages 141-147.
Crossref
Crossref
Fangjian Guo, Leslie E. Cofie & Abbey B. Berenson. (2018) Cervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction. American Journal of Preventive Medicine 55:2, pages 197-204.
Crossref
Crossref
Hong-Lu Zhou, Wei Zhang, Can-Jing Zhang, Song-Mei Wang, Ya-Chen Duan, Jin-Xia Wang, Huan Yang & Xuan-Yi Wang. (2018) Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review. Journal of Infection.
Crossref
Crossref
Jacqueline M. Hirth, Denise N. Batuuka, Tyra T. Gross, Leslie Cofie & Abbey B. Berenson. (2018) Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program. Vaccine 36:8, pages 1032-1037.
Crossref
Crossref
Fangjian GuoJacqueline M. HirthAbbey B. Berenson. (2017) Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. Journal of Women's Health 26:10, pages 1114-1122.
Crossref
Crossref
Leonard F. Vernon. (2017) How Silencing of Dissent in Science Impacts Woman. The Gardasil® Story. Advances in Sexual Medicine 07:04, pages 179-204.
Crossref
Crossref
Purnima Madhivanan, Dudith Pierre-Victor, Soumyadeep Mukherjee, Prasad Bhoite, Brionna Powell, Naomie Jean-Baptiste, Rachel Clarke, Tenesha Avent & Karl Krupp. (2016) Human Papillomavirus Vaccination and Sexual Disinhibition in Females. American Journal of Preventive Medicine 51:3, pages 373-383.
Crossref
Crossref